Jmac Enterprises LLC Merck & Co., Inc. Transaction History

Jmac Enterprises LLC

$610 Million
Q3 2024

A detailed history of Jmac Enterprises LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jmac Enterprises LLC holds 19,867 shares of MRK stock, worth $1.97 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

19,867

Previous 18,301 8.56%

Holding current value

$1.97 Million

Previous $2.27 Million 0.4%

% of portfolio

0.37%

Previous 0.41%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$111.15 - $128.97 $174,060 - $201,967	1,566 Added 8.56%	19,867 $2.26 Million
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $1.03 Million - $1.11 Million	-8,347 Reduced 31.32%	18,301 $2.27 Million
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $1,132 - $1,319	10 Added 0.04%	26,648 $3.52 Million
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $29,052 - $31,615	-290 Reduced 1.08%	26,638 $2.9 Million
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $33,664 - $37,385	327 Added 1.23%	26,928 $2.77 Million
Q2 2023 Jul 20, 2023	BUY	$108.61 - $118.38 $161,720 - $176,267	1,489 Added 5.93%	26,601 $3.07 Million
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $264,967 - $295,649	2,574 Added 11.42%	25,112 $2.67 Million
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $115,683 - $148,321	1,323 Added 6.24%	22,538 $0
Q3 2022 Oct 20, 2022	BUY	$84.53 - $94.96 $5,071 - $5,697	60 Added 0.28%	21,215 $1.83 Million
Q2 2022 Jul 25, 2022	BUY	$83.49 - $94.64 $35,566 - $40,316	426 Added 2.06%	21,155 $1.93 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $34,549 - $38,728	470 Added 2.32%	20,729 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.46 Million - $1.83 Million	20,259 New	20,259 $1.55 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jmac Enterprises LLC with notifications on news.

Account

Jmac Enterprises LLC Merck & Co., Inc. Transaction History